I agree, all the other risks are just systematic risks that equally apply to all biotechs. Risk needs to be assessed ‘relative’ to other companies. Next hurdle or risk is does CPACS translate to the clinic. If you are invested you are of the opinion it will, unless you are looking for an AML (only) outcome.
- Forums
- ASX - By Stock
- Cardioprotection thread
I agree, all the other risks are just systematic risks that...
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M |
Open | High | Low | Value | Volume |
$1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1996 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 1305 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4387 | 1.600 |
1 | 31000 | 1.590 |
1 | 10000 | 1.585 |
2 | 8233 | 1.560 |
4 | 15571 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.690 | 585 | 1 |
1.700 | 17181 | 1 |
1.750 | 30400 | 2 |
1.755 | 990 | 1 |
1.820 | 1000 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |